UNITED KINGDOM
New
 

- French Pavilion highlights biotech expertise at Genesis 2009

London - 23/11/09

French Pavilion highlights biotech expertise at Genesis 2009
  

The French Trade Commission UBIFRANCE in the UK will showcase 10 innovative French companies from the biotechnology and pharmaceutical industries on the French Pavilion (Stands 1-6 and 26a-27 in the Flemming Room) at the Genesis Conference, to be held in London at the QE2 Conference Centre on 10 and 11 December 2009.
 
The French Pavilion will offer a unique environment in which company representatives can discover new products and find potential clients and business partners. The exhibiting companies will showcase a range of innovative products and services in the biotech, pharma and healthcare sectors. These companies are aiming to reinforce their professional contacts and explore new business opportunities between France and the UK.
 
All aspects of the industry will be covered by the French Pavilion, including drug discovery and development, Contract Research Organisations (CRO), Contract Manufacturing Organisations (CMO), business consultancies, recruitment, distribution and logistics, as well as software.
 
Companies on the French stand are listed below; further information about the exhibitors is available on request.
 
Actini
 
Actini, a specialist in sterilisation technology, manufactures biowaste inactivation systems and growth media sterilisers. Actini’s systems meet the most stringent standards and satisfy the requirements of bioindustries and laboratories with a range of capacities from 100 litres per day to 30,000 litres per hour.
 
For further information, please go to: www.actini.com/gb/pharmaceutical.htm
 
Aderly Associates
 
Aderly, the Lyons Area Economic Development Agency, supports and advises companies at every stage from set-up to development projects. Its services include business networking and setting up qualified meetings with potential customers or partners in the Lyons area of south-eastern France.
 
For further information, please go to: www.aderly.com
 
Bioquanta
 
Bioquanta provides services for biopharmaceutical companies involved in drug discovery and development. Its in silico platform provides toxicity predictions on 12 endpoints. The in vitro platform provides results on mitochondrial, oxidative stress, inflammation and cell death assays.
 
For further information, please go to: www.bioquanta.net
 
Chelatec
 
Chelatec is a CRO in the life-sciences sector, with a strong technological platform and unique expertise in providing applied services relating to customised radio-labelling and in vivo investigation of labelled drugs.
For further information, please go to: www.chelatec.fr
 
Citox
Citox is a leading CRO specialising in pre-clinical and safety evaluation studies. Citox offers a full range of services, including general toxicology in rodents and non-rodents; developmental and reproductive toxicology; carcinogenicity and safety pharmacology; and genomics.
 
For further information, please go to: www.citox.com
 
Créapharm MP5
 
Créapharm MP5 is a CMO specialising in the formulation, fill–finish and lyophilisation of targeted parenteral therapies for small-scale, Phase I and Phase II oncology clinical trials. In addition, the company provides services in the worldwide distribution of clinical samples.
 
For further information, please go to: www.creapharm.fr
 
Kayentis
 
Kayentis is a software company specialising in life sciences. The company’s solutions for the dematerialisation and intermediation of handwritten data meet the requirements of the pharmaceutical and healthcare sectors.
 
For further information, please go to: www.kayentis.com
 
Pact & Partners
 
Pact & Partners is a global recruitment consultancy with offices in Paris, London, Madrid, Copenhagen and Lausanne, as well as partners worldwide. Pact & Partners is dedicated to the life-sciences industry (pharma, biotech, medical devices, cosmetics and private equity).
 
For further information, please go to: www.pactpartners.com
 
Prestwick Chemical
 
Prestwick Chemical is a drug-discovery CRO that optimises hits into clinical candidates. The company offers fully integrated drug research – hit identification using smart screening libraries, hit validation, hit to lead expansion, lead optimisation and profiling.
 
For further information, please go to: www.prestwickchemical.com  
 
Universal Biotech
 
Universal Biotech, a subsidiary of Universal Medica Group, is a consulting firm dedicated to biotechnology. Universal Biotech works with an international network of leading pharma and biotech companies, research centres and venture capital firms, and now covers Europe, the USA and Asia.
 
For further information, please go to: www.universal-biotech.com
 
About the French Trade Commission UBIFRANCE in the UK
 
The Trade Commission of the French Embassy in London promotes trade development between France and the UK by offering a range of services to French companies. The New Technology Department organises B2B meetings in the form of conferences and networking events, mainly in London. 
                   
The Genesis Conference will take place at the QE2 Conference Centre in London (UK) on 10 and 11 December between 8.30am and 5.30pm (on the last day, the conference closes at 1.30pm). The French Pavilion can be found at Stands 1-6, 26A-27 in the Flemming Room.
 
For further information, you can contact the Trade Commission in London directly (see below).
 
Mrs Teresa Marshall
Trade Development Adviser, UBIFRANCE London
Telephone: 0207 024 3644
 
Mrs Priyanka Sonavane
Export Development Adviser, UBIFRANCE London
Telephone: 0207 024 3646
 
FOR MORE INFORMATION, PLEASE CONTACT:
Kate AMBLER – Press Officer
UBIFRANCE Press Office in London
Telephone: 0207-024-3640
Web site: www.ftpb.co.uk
 
 
UBIFRANCE UK #3351
 
< Return  Contents